Clinical trial of duration of immunity of the yellow fever vaccine in army recruits, participants of the study “17DD yellow fever vaccine. A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study”, done in 2009 (360G-Wellcome-206523_Z_17_Z)

£78,100

PRIMARY:To evaluate duration of immunity of the 17DD yellow fever vaccine when applied in reduced doses. SECONDARY:To evaluate the individual repertoire of immunoglobulins directed to yellow fever epitopes in participants of the study "17DD yellow fever vaccine. A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study", done in 2009. To evaluate the phenotypical/functional profile of cellular memory against yellow fever in individuals in against yellow fever of participants of the study "17DD yellow fever vaccine. A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study", done in 2009.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 78100
Applicant Surname de Menezes Martins
Approval Committee Internal Decision Panel
Award Date 2017-05-15T00:00:00+00:00
Financial Year 2016/17
Grant Programme: Title Zika Initiative Award
Internal ID 206523/Z/17/Z
Lead Applicant Dr Reinaldo de Menezes Martins
Partnership Name Zika Research Support Initiative
Partnership Value 156200
Planned Dates: End Date 2018-05-31T00:00:00+00:00
Planned Dates: Start Date 2017-03-27T00:00:00+00:00
Recipient Org: Country Brazil
Region International